| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.41 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |